719 related articles for article (PubMed ID: 9179973)
21. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma.
Lee MG; Kim HY; Byun DS; Lee SJ; Lee CH; Kim JI; Chang SG; Chi SG
Cancer Res; 2001 Sep; 61(18):6688-92. PubMed ID: 11559536
[TBL] [Abstract][Full Text] [Related]
22. Bladder cancer.
Ozen H
Curr Opin Oncol; 1998 May; 10(3):273-8. PubMed ID: 9619365
[TBL] [Abstract][Full Text] [Related]
23. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
24. Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer.
Lin SH; Pu YS
Semin Oncol; 1999 Apr; 26(2):227-33. PubMed ID: 10597733
[TBL] [Abstract][Full Text] [Related]
25. [TP53 mutations and molecular epidemiology].
Otsuka K; Ishioka C
Gan To Kagaku Ryoho; 2007 May; 34(5):683-9. PubMed ID: 17496437
[TBL] [Abstract][Full Text] [Related]
26. Genetic alterations underlying colorectal tumorigenesis.
Fearon ER
Cancer Surv; 1992; 12():119-36. PubMed ID: 1638544
[TBL] [Abstract][Full Text] [Related]
27. The retinoblastoma gene: a prototypic and multifunctional tumor suppressor.
Zheng L; Lee WH
Exp Cell Res; 2001 Mar; 264(1):2-18. PubMed ID: 11237519
[TBL] [Abstract][Full Text] [Related]
28. [Somatic genetics of breast cancer].
Bièche I; Lidereau R
Bull Cancer; 1997 Jan; 84(1):83-96. PubMed ID: 9180865
[TBL] [Abstract][Full Text] [Related]
29. [Tracking the gatekeeper gene in the stages of carcinogenesis in the bladder].
Baud E; Catilina P; Bignon YJ
Bull Cancer; 1997 Oct; 84(10):971-5. PubMed ID: 9435799
[TBL] [Abstract][Full Text] [Related]
30. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
[TBL] [Abstract][Full Text] [Related]
31. Heterozygous Aprt mouse model: detection and study of a broad range of autosomal somatic mutations in vivo.
Vrieling H; Wijnhoven S; van Sloun P; Kool H; Giphart-Gassler M; van Zeeland A
Environ Mol Mutagen; 1999; 34(2-3):84-9. PubMed ID: 10529730
[TBL] [Abstract][Full Text] [Related]
32. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA
Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661
[TBL] [Abstract][Full Text] [Related]
33. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
[TBL] [Abstract][Full Text] [Related]
34. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
35. [Tumor suppressor genes: mutations in RB and p53 genes are significant carcinogenic factors].
Wiman KG
Lakartidningen; 1992 Sep; 89(39):3169-74. PubMed ID: 1405928
[TBL] [Abstract][Full Text] [Related]
36. Molecular biology of bladder cancer.
Borland RN; Brendler CB; Isaacs WB
Hematol Oncol Clin North Am; 1992 Feb; 6(1):31-9. PubMed ID: 1556051
[TBL] [Abstract][Full Text] [Related]
37. [Molecular basis of cancer].
Meza-Junco J; Montaño-Loza A; Aguayo-González A
Rev Invest Clin; 2006; 58(1):56-70. PubMed ID: 16789600
[TBL] [Abstract][Full Text] [Related]
38. The molecular genetics of retinoblastoma.
Goodrich DW; Lee WH
Cancer Surv; 1990; 9(3):529-54. PubMed ID: 2101724
[TBL] [Abstract][Full Text] [Related]
39. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.
Osada H; Takahashi T
Oncogene; 2002 Oct; 21(48):7421-34. PubMed ID: 12379883
[TBL] [Abstract][Full Text] [Related]
40. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]